I’ve spent a lot of the last few days comforting family members, friends, and many of my students who were feeling traumatized. And in comforting them, I’ve realized that I have a small sliver of hope about our future. Perhaps it’s pure naïveté, but I have hope that there’s at least one person in the Republican leadership with a bit of common sense. And I hope this person will be able to slow the knee-jerk agenda of the alt-right or the Freedom Caucus.
For better and worse, American medicine is increasingly controlled by large corporate entities and Obamacare is accelerating the transition. Observers including me who see our medicine as highly inefficient view this trend as an opportunity to impose rationality, but there are also clearly pitfalls. Continue reading Bigger American Medicine May Be Better
If the good news we’ve been hearing about American health costs in the past few months turns out to be the new norm – it’s too early to tell – then much of today’s political debate is wildly misguided. Consultants predict 2014 will see abnormally low inflation, again. Medicare spending per beneficiary is dropping more than previously anticipated. And new tools provided by Obamacare to constrain costs could accelerate these trends. Continue reading So What’s the Problem?
If you were a recent college grad or drop out with no job or underemployed or selling your mind and body as an unpaid intern, do you give a (bleep) about the Koch brothers? Continue reading In Search of a Message — Dems Have a Way to Go
Is it wise policy to encourage Americans who already spend more than $8 billion annually on these tests to get more? And why does Obamacare, which generally favors evidence-based medicine, mandate this service despite new research suggesting mammograms don’t save lives.
Despite our discomfort with a public debate, our healthcare system is constantly asked what treatments are worth paying for. Continue reading The Bang Of Your Medical Buck